Berkshire Money Management’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Berkshire Money Management’s Portfolio FRTX Stock Details FRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-12	Closed	-$15K	–	29
2016 Q1	$15K	Hold	12	–	–	﹤0.01%	26
2015 Q4	$15.4K	Hold	12	–	–	﹤0.01%	22
2015 Q3	$40K	Hold	12	–	–	0.01%	18
2015 Q2	$26K	Hold	12	–	–	0.01%	19
2015 Q1	$36K	Hold	12	–	–	0.01%	19
2014 Q4	$40K	Hold	12	–	–	0.01%	18
2014 Q3	$42K	Hold	12	–	–	0.02%	17
2014 Q2	$45.9K	Hold	12	–	–	0.03%	12
2014 Q1	$49K	Buy	12 +4	+50%	+$17.9K	0.02%	15
2013 Q4	$31K	Buy	+8	New	+$30.3K	0.01%	17

Other funds holding FRTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

CAM

ClariVest Asset Management San Diego, California $980M AUM 60.89% 1-Year Est. Return

EGA

Eagle Global Advisors Houston, Texas $3.02B AUM 34.37% 1-Year Est. Return

Berkshire Money Management's FRTX Position: Q2 2016 in Review

Berkshire Money Management sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q2 2016, closing a stake of 12 shares — an estimated $15K sold.

Berkshire Money Management first reported a position in FRTX in Q4 2013 and held it in 10 quarters. The position peaked at $49K in Q1 2014. 36 funds tracked by Wall St. Rank hold FRTX as of Q2 2016.

Berkshire Money Management reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q2 2016 after selling out during the quarter.
Berkshire Money Management sold 12 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q2 2016, an estimated $15K.
Berkshire Money Management first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q4 2013 and held it in 10 quarters.
Berkshire Money Management's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $49K in Q1 2014.
36 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q2 2016.

Based on Berkshire Money Management's 13F filing for Q2 2016, filed 26 Aug 2016.